GlaxoSmithKline Australia
Administration route: 
Subcutaneous injection
Vaccine group: 
Monovalent vaccines

Registered for use in people aged ≥9 months.

Monovalent varicella vaccine

Lyophilised powder in a monodose vial with separate diluent.

Each 0.5 mL reconstituted dose contains:

  • ≥103.3 plaque-forming units of live attenuated varicella-zoster virus (Oka strain)
  • lactose
  • mannitol
  • sorbitol
  • neomycin

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018